Clinical Trial Update: Trial of Extended Release Bupivacaine for Pain Relief After Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of Extended Release Bupivacaine for post-operative pain completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• extended-release bupivacaine (bupivacaine (extended-release formulation))

Snippet

Sponsor: Durect | Conditions: Post Operative Pain | Phase 3 | Status: COMPLETED | Results posted: 2021-07-13